Dan Quam

Dan Quam is a seasoned professional in the oncology and biopharmaceutical sectors with extensive experience spanning over two decades. Currently serving as the Director of KOL/Thought Leader Liaison at Acrotech Biopharma, LLC, and the Director of KOL/Thought Leader Development at Spectrum Pharma, Dan has a strong background in oncology sales and marketing. Previous roles include Senior Oncology Account Manager and Clinical Oncology Manager, with notable contributions to the launch of Folotyn for relapsed/refractory T-cell lymphoma. Dan's career encompasses key positions at Eisai, MGI Pharma, Gilford Pharma, Scios Biotech, and Aventis Pharmaceuticals, where responsibilities included promoting innovative treatments for various oncological conditions. Dan holds a BA in Marketing/Business from California State University, Chico.